← Eichor
Study identifier: NCT06700174 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Lifetech AcuMark™ Sizing Balloon Post-Market Clinical Follow-up Study

Condition: Atrial Septal Defect (ASD)  ·  Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd.

PhaseN/A
Planned participants100
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

The objective of this PMCF study is to: * confirm the safety and performance of the AcuMarkTM Sizing Balloon * identify previously unknown side-effects * monitor the identified side-effects (related to the procedure or to the medical devices)

This description comes directly from the study's public registry record.

Talk to the study team

Shen Yuanyuan  ·  86+18504356312  ·  shenyuanyuan@lifetechmed.com

Fu Jiaxuan  ·  86 13973207184  ·  fujiaxuan@lifetechmed.com

Always discuss trial participation with your own doctor first.

Locations (5)

Ankara (Bilkent) City HospitalAnkara, Turkey (Türkiye)Recruiting
Gazi Yasargil Woman and Child HospitalDiyarbakır, Turkey (Türkiye)Recruiting
Gaziantep University HospitalGaziantep, Turkey (Türkiye)Not Yet Recruiting
SiyamiErsek Thoracic and Cardiovascular Surgery Training and Research HospitalIstanbul, Turkey (Türkiye)Not Yet Recruiting
Tepecik Training and Research HospitalIzmir, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06700174